CYP24A1型
化学
骨化三醇受体
突变体
酶
维生素D与神经学
活动站点
作者
Hiromi Hamamoto,Tatsuya Kusudo,Naoko Urushino,Hiroyuki Masuno,Keiko Yamamoto,Sachiko Yamada,Masaki Kamakura,Miho Ohta,Kuniyo Inouye,Toshiyuki Sakaki
出处
期刊:Molecular Pharmacology
[American Society for Pharmacology & Experimental Therapeutics]
日期:2006-07-01
卷期号:70 (1): 120-128
被引量:42
标识
DOI:10.1124/mol.106.023275
摘要
Our previous studies revealed the species-based difference of CYP24A1-dependent vitamin D metabolism. Although human CYP24A1 catalyzes both C-23 and C-24 oxidation pathways, rat CYP24A1 shows almost no C-23 oxidation pathway. We tried to identify amino acid residues that cause the species-based difference by site-directed mutagenesis. In the putative substrate-binding regions, amino acid residue of rat CYP24A1 was converted to the corresponding residue of human CYP24A1. Among eight mutants examined, T416M and I500T showed C-23 oxidation pathway. In addition, the mutant I500F showed quite a different metabolism of 1alpha,25-dihydroxyvitamin D3 [1alpha,25(OH)2D3] from both human and rat CYP24A1. These results strongly suggest that the amino acid residues at positions 416 and 500 play a crucial role in substrate binding and greatly affect substrate orientation. A three-dimensional model of CYP24A1 indicated that the A-ring and triene part of 1alpha,25(OH)2D3 could be located close to amino acid residues at positions 416 and 500, respectively. Our findings provide useful information for the development of new vitamin D analogs for clinical use.
科研通智能强力驱动
Strongly Powered by AbleSci AI